4.11
price down icon10.85%   -0.50
after-market Handel nachbörslich: 4.14 0.03 +0.73%
loading
Schlusskurs vom Vortag:
$4.61
Offen:
$4.5
24-Stunden-Volumen:
1.94M
Relative Volume:
2.40
Marktkapitalisierung:
$462.37M
Einnahmen:
$69.56M
Nettoeinkommen (Verlust:
$-240.05M
KGV:
-1.3932
EPS:
-2.95
Netto-Cashflow:
$-121.90M
1W Leistung:
-4.64%
1M Leistung:
+24.17%
6M Leistung:
+239.67%
1J Leistung:
+34.31%
1-Tages-Spanne:
Value
$4.08
$4.625
1-Wochen-Bereich:
Value
$4.08
$4.74
52-Wochen-Spanne:
Value
$1.05
$4.74

Adc Therapeutics Sa Stock (ADCT) Company Profile

Name
Firmenname
Adc Therapeutics Sa
Name
Telefon
41 21 653 02 00
Name
Adresse
BIOPOLE, EPALINGES
Name
Mitarbeiter
263
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-21
Name
Neueste SEC-Einreichungen
Name
ADCT's Discussions on Twitter

Vergleichen Sie ADCT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ADCT
Adc Therapeutics Sa
4.11 497.25M 69.56M -240.05M -121.90M -2.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.22 104.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.36 60.95B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.11B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.95 49.23B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.94 35.92B 4.56B -176.77M 225.30M -1.7177

Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-08 Eingeleitet Stephens Overweight
2024-05-30 Eingeleitet Cantor Fitzgerald Overweight
2024-03-28 Eingeleitet Guggenheim Buy
2023-08-10 Hochstufung JP Morgan Underweight → Neutral
2023-04-24 Herabstufung BofA Securities Neutral → Underperform
2022-12-06 Eingeleitet CapitalOne Overweight
2022-11-09 Herabstufung BofA Securities Buy → Neutral
2022-09-21 Eingeleitet JP Morgan Overweight
2022-09-09 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-11-09 Eingeleitet Wolfe Research Outperform
2021-08-17 Fortgesetzt Jefferies Buy
2021-08-09 Eingeleitet RBC Capital Mkts Outperform
2021-06-15 Eingeleitet Cantor Fitzgerald Overweight
2020-12-03 Eingeleitet Stifel Hold
2020-10-29 Eingeleitet H.C. Wainwright Buy
2020-06-09 Eingeleitet BofA/Merrill Buy
2020-06-09 Eingeleitet Cowen Outperform
Alle ansehen

Adc Therapeutics Sa Aktie (ADCT) Neueste Nachrichten

pulisher
04:21 AM

Wealth Enhancement Advisory Services LLC Sells 3,758 Shares of ADC Therapeutics SA $ADCT - Defense World

04:21 AM
pulisher
02:53 AM

What insider trading reveals about ADC Therapeutics SA stockJuly 2025 Technicals & Real-Time Volume Analysis Alerts - newser.com

02:53 AM
pulisher
Oct 13, 2025

ADC Therapeutics SA announced that it expects to receive $60.02 million in funding - MarketScreener

Oct 13, 2025
pulisher
Oct 13, 2025

Should you wait for a breakout in ADC Therapeutics SAEarnings Overview Summary & AI Forecast Swing Trade Picks - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

ADC Therapeutics rises on $60M PIPE financing - MSN

Oct 13, 2025
pulisher
Oct 13, 2025

ADC Therapeutics raises $60 million in private placement financing - Investing.com India

Oct 13, 2025
pulisher
Oct 13, 2025

ADC Therapeutics raises $60 million in private placement financing By Investing.com - Investing.com Nigeria

Oct 13, 2025
pulisher
Oct 13, 2025

ADC Therapeutics Announces $60 Million Private Placement - PR Newswire

Oct 13, 2025
pulisher
Oct 13, 2025

Visual analytics tools that track ADC Therapeutics SA performanceQuarterly Growth Report & Detailed Earnings Play Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Published on: 2025-10-13 01:51:42 - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Published on: 2025-10-12 23:16:07 - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Using flow based indicators on ADC Therapeutics SAJuly 2025 Technicals & Fast Exit Strategy with Risk Control - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

What technical models suggest about ADC Therapeutics SA’s comeback2025 Short Interest & Fast Gaining Stock Reports - newser.com

Oct 11, 2025
pulisher
Oct 10, 2025

Key metrics from ADC Therapeutics SA’s quarterly dataPortfolio Update Report & Low Risk Investment Opportunities - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Risk adjusted return profile for ADC Therapeutics SA analyzedJuly 2025 EndofMonth & Verified Technical Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Weiss Ratings Reiterates “Sell (D-)” Rating for ADC Therapeutics (NYSE:ADCT) - Defense World

Oct 10, 2025
pulisher
Oct 10, 2025

Using R and stats models for ADC Therapeutics SA forecastingMarket Growth Summary & Safe Capital Investment Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

What hedge fund moves indicate for ADC Therapeutics SA Common Shares stockMarket Growth Report & Daily Market Momentum Tracking - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

ADC Therapeutics SA stock daily chart insightsJuly 2025 Intraday Action & Growth Focused Entry Point Reports - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

ADC Therapeutics (NYSE:ADCT) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

ADC Therapeutics SA (NYSE:ADCT) Receives $7.75 Consensus PT from Brokerages - Defense World

Oct 08, 2025
pulisher
Oct 07, 2025

ADC Therapeutics SA Hits New 52-Week High of $4.67 - Markets Mojo

Oct 07, 2025
pulisher
Oct 07, 2025

ADC Therapeutics SA (NYSE:ADCT) Stock Catapults 25% Though Its Price And Business Still Lag The Industry - 富途牛牛

Oct 07, 2025
pulisher
Oct 07, 2025

ADC Therapeutics Gains Ground Ahead Of LOTIS-7 Expansion, LOTIS-5 Readout - RTTNews

Oct 07, 2025
pulisher
Oct 06, 2025

ADC Therapeutics targets $600M–$1B peak revenue potential for ZYNLONTA amid strategic refocus and cost cuts - MSN

Oct 06, 2025
pulisher
Oct 06, 2025

Analysts Offer Predictions for ADCT Q3 Earnings - Defense World

Oct 06, 2025
pulisher
Oct 06, 2025

ADC Therapeutics SA Hits New 52-Week High of USD 4.31 - Markets Mojo

Oct 06, 2025
pulisher
Oct 06, 2025

ADC Therapeutics (NYSE:ADCT) Sets New 52-Week HighStill a Buy? - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Order flow analysis tools used on ADC Therapeutics SAEntry Point & Low Drawdown Trading Strategies - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Understanding ADC Therapeutics SA’s price movementTrade Risk Assessment & Daily Technical Forecast Reports - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Analyzing recovery setups for ADC Therapeutics SA investorsMarket Risk Summary & Stepwise Trade Execution Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why analysts maintain buy rating on ADC Therapeutics SA Common Shares stock2025 Market Overview & Daily Risk Controlled Trade Plans - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

ADC Therapeutics SA (NYSE:ADCT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Oct 05, 2025
pulisher
Oct 03, 2025

What is the fair value estimate for ADC Therapeutics SA Common Shares stock in 2025Take Profit & Fast Momentum Entry Tips - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Intraday pattern recognizer results for ADC Therapeutics SAPortfolio Risk Summary & Verified Entry Point Signals - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Platinum Investment Management Ltd. Cuts Stock Holdings in ADC Therapeutics SA $ADCT - MarketBeat

Oct 02, 2025

Finanzdaten der Adc Therapeutics Sa-Aktie (ADCT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):